Source: Annual Congress 2006 - Hypoxic and inflammatory insults to the pulmonary circulation.
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Papakonstantinou, F. Kouri, I. Klangas, G. Karakiulakis, O. Eickelberg (Thessaloniki, Greece; Giessen, Germany). Alterations in the expression of proteoglycans and glycosaminoglycans in pulmonary hypertension. Eur Respir J 2006; 28: Suppl. 50, 3827

Member's Comments

No comment yet.

Related content which might interest you: Fine structural modifications of heparan sulfate sulfation patterns in lung are associated with functional effects in Precapillary Pulmonary Hypertension Source: International Congress 2018 – Pathobiology of pulmonary hypertension Year: 2018 Diaphragm dysfunction in chronic obstructive pulmonary disease: a role for heparan sulphate? Source: Eur Respir J 2007; 30: 80-89 Year: 2007 Changes in xylosyltransferase activity and in proteoglycan deposition in bleomycin-induced lung injury in rat Source: Eur Respir J 2001; 18: 347-356 Year: 2001 Lung heparan and chondroitine sulfate imbalance and functional changes in pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: pathobiology Year: 2014 Alternative Polyadenylation(APA) modulates extracellular matrix deposition in pulmonary hypertension Source: ERS Lung Science Conference 2018 Year: 2018 Perlecan and heparan sulphate are abundant in fibroblast foci in Idiopathic Pulmonary Fibrosis. Source: International Congress 2017 – Novel pro- and anti-fibrotic mechanisms in pulmonary fibrosis Year: 2017 Altered expression of adhesion molecules in circulating neutrophils of patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2002; 20: Suppl. 38, 479s Year: 2002 The Role of Inflammation in promoting pulmonary hypertension in idiopatchi and connective tissue disease-associated PAH Source: Research Seminar 2008 - The Pulmonary Circulation: Scleroderma-Related Pulmonary Arterial Hypertension Year: 2008 Collagen V and decorin is involved in systemic sclerosis pulmonary fibrosis Source: Annual Congress 2011 - The ageing pulmonary interstitium Year: 2011 Matrix proteoglycans as effector molecules for epithelial cell function Source: Eur Respir Rev 2005; 14: 137-144 Year: 2005 Age-dependent elastin degradation is enhanced in chronic obstructive pulmonary disease Source: Eur Respir J 2016; 48: 1215-1218 Year: 2016 Gene expression alterations in mice lacking the VIP gene are conducive to pulmonary arterial hypertension and pulmonary vascular remodeling Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension Year: 2007 Pulmonary gene expression of tenascin-C and fibronectin in chronic obtructive pulmonary disease (COPD) Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments Year: 2012 Progression of monocrotaline-induced pulmonary hypertension in rats can be monitored by plasma activity of matrix metalloproteinase-2 and plasma levels of tenascin-C and proBNP Source: Eur Respir J 2007; 30: Suppl. 51, 7s Year: 2007 Increased levels of glycosaminoglycans in lungs from patients with IPF Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Pathobiology of pulmonary arterial hypertension Source: Eur Respir J 2002; 20: 1559-1572 Year: 2002 Cellular microparticles in the pathogenesis of pulmonary hypertension Source: Eur Respir J 2013; 42: 272-279 Year: 2013 Role of endothelin in lung fibrosis Source: Eur Respir Rev 2008; 17: 145-150 Year: 2008 Increased hyaluronic acid content in idiopathic pulmonary arterial hypertension Source: Eur Respir J 2008; 32: 1504-1512 Year: 2008